Stocks and Investing Stocks and Investing
Mon, August 14, 2023

Kevin Steinke Maintained (CCRN) at Buy with Decreased Target to $29 on, Aug 14th, 2023


Published on 2024-10-28 05:53:16 - WOPRAI, Kevin Steinke
  Print publication without navigation


Kevin Steinke of Barrington Research, Maintained "Cross Country Healthcare, Inc." (CCRN) at Buy with Decreased Target from $35 to $29 on, Aug 14th, 2023.

Kevin has made no other calls on CCRN in the last 4 months.



There are 3 other peers that have a rating on CCRN. Out of the 3 peers that are also analyzing CCRN, 2 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jonathan Yong of "Credit Suisse" Maintained at Hold with Decreased Target to $26 on, Tuesday, August 8th, 2023
  • Tobey Sommer of "Truist Securities" Maintained at Hold with Decreased Target to $25 on, Tuesday, May 2nd, 2023


This is the rating of the analyst that currently disagrees with Kevin


  • Trevor Romeo of "William Blair" Initiated at Buy on, Monday, June 26th, 2023
Contributing Sources